Assignee
ONCOTRACKER INC
US·2 granted patents·4 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
6 records- 0166US11246876B2Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivatives and glucocorticoidsONCOTRACKER INC·Filed 2019·Granted Feb 15, 2022·0 cites·24 claims
- 0266US2023233579A1Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoidsONCOTRACKER INC·Filed 2022·Application pending·0 cites
- 0365US2023405124A1Gamma secretase modulators for the treatment of immune system dysfunctionONCOTRACKER INC·Filed 2023·Application pending·0 cites
- 0447US2022000872A1Method of enhancing immune-based therapyONCOTRACKER INC·Filed 2019·Application pending·0 cites
- 0545US2018214553A1Gamma secretase modulators for the treatment of immune system dysfunctionONCOTRACKER INC·Filed 2016·Application pending·0 cites
- 0638US11635435B2Diagnostic, prognostic, and monitoring methods for solid tumor cancersONCOTRACKER INC·Filed 2018·Granted Apr 25, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when ONCOTRACKER INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →